Chronic lymphocytic leukemia (CLL) B cells and tumor microenvironment (TME) bystander cells incite a tolerogenic environment through soluble factors (e.g., IL-10) and immune inhibitory molecules (e.g., PD-L1, LAG3) (1). This evidence concerns the gene CD274 and B-cell chronic lymphocytic leukemia.